ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.68
      -0.78%
      Bitcoin
      62,942.27
      -2.94%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. IDEAYA Biosciences Inc (IDYA)

      7. IDEAYA Biosciences Inc (IDYA) News

      IDYA

      IDEAYA Biosciences (IDYA)

      IDEAYA Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDYA
      DateTimeSourceHeadlineSymbolCompany
      03/01/20226:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in March 2022NASDAQ:IDYAIDEAYA Biosciences Inc
      02/18/20225:18PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20222:43PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20221:43PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20229:19AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20228:44AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20226:23AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/04/20224:22PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/01/20226:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in February 2022NASDAQ:IDYAIDEAYA Biosciences Inc
      01/31/20226:00AMPR Newswire (US)IDEAYA Advances First-in-Class PARG Development Candidate, IDE161, into IND-Enabling Studies and Exercises Option with Cancer Research UK and University of Manchester for Exclusive Worldwide LicenseNASDAQ:IDYAIDEAYA Biosciences Inc
      01/25/20229:33AMTipRanksIDEAYA Biosciences, Inc. Updates 1 Key Risk FactorNASDAQ:IDYAIDEAYA Biosciences Inc
      01/10/20226:00AMPR Newswire (US)IDEAYA Biosciences Announces Corporate and Portfolio Update for J.P. Morgan 40th Annual Healthcare ConferenceNASDAQ:IDYAIDEAYA Biosciences Inc
      01/05/20226:00AMPR Newswire (US)IDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery PlatformNASDAQ:IDYAIDEAYA Biosciences Inc
      01/04/20226:00AMPR Newswire (US)IDEAYA Biosciences Appoints Dr. Frank McCormick as Chair of Scientific Advisory BoardNASDAQ:IDYAIDEAYA Biosciences Inc
      01/03/20226:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in January 2022NASDAQ:IDYAIDEAYA Biosciences Inc
      12/07/20217:00AMPR Newswire (US)IDEAYA Reports Clinical Data from Phase 2 Expansion Dose of Darovasertib and Crizotinib Synthetic Lethal Combination in Heavily Pre-Treated Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      12/01/202111:05AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      11/30/20216:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in December 2021NASDAQ:IDYAIDEAYA Biosciences Inc
      11/29/20216:00AMPR Newswire (US)IDEAYA Announces Investor Webcast to Review Clinical Data from Phase 1/2 Trial of Darovasertib Combination with Crizotinib in Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      11/15/20214:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDYAIDEAYA Biosciences Inc
      11/15/20216:01AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
      11/01/20216:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in November 2021NASDAQ:IDYAIDEAYA Biosciences Inc
      10/18/20216:00AMPR Newswire (US)IDEAYA Biosciences Appoints Michael White, Ph.D., as Chief Scientific OfficerNASDAQ:IDYAIDEAYA Biosciences Inc
      10/07/20214:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      09/09/20215:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      09/07/20216:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      08/30/20216:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in September 2021NASDAQ:IDYAIDEAYA Biosciences Inc
      08/11/20215:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      08/11/20214:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      08/10/20216:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:IDYA

      Your Recent History

      USOTC
      WECFF
      White Energy (PK)
      Delayed Upgrade Clock